Suven Life Sciences Limited · NSE: SUVEN · BSE: 530239
Suven Life Sciences
Quarterly results as filed with BSE. Latest: Q1 FY27 (Apr–Jun 2026), filed 06 Aug 2026.
Q1 FY27 · Consolidated
Revenue
3.57₹ Cr
+91.0% vs year ago
Net profit
(127.61)₹ Cr
Loss widened vs year ago
EPS, basic
(4.84)₹
not comparable vs year ago
Net margin
-3578.7%
−818.9 pts vs year ago
Quarter by quarter
| Quarter | Revenue | YoY | Net profit | YoY | EPS (₹) | Filed |
|---|---|---|---|---|---|---|
| Q1 FY27Apr–Jun 2026 | 3.57 | +91.0% | (127.61) | Loss widened | (4.84) | 06 Aug 2026 |
| Q4 FY26Jan–Mar 2026 | 1.52 | +3.6% | (45.60) | Loss widened | (2.02) | 28 May 2026 |
| Q3 FY26Oct–Dec 2025 | 2.81 | +74.5% | (101.92) | Loss widened | (4.55) | 29 Jan 2026 |
| Q2 FY26Jul–Sep 2025 | 0.92 | −64.3% | (77.31) | Loss widened | (3.48) | 11 Nov 2025 |
| Q1 FY26Apr–Jun 2025 | 1.87 | +85.6% | (51.52) | Loss widened | (2.36) | 13 Aug 2025 |
| Q4 FY25Jan–Mar 2025 | 1.47 | −38.5% | (43.94) | Loss widened | (2.02) | 13 May 2025 |
| Q3 FY25Oct–Dec 2024 | 1.61 | −34.3% | (39.12) | Loss narrowed | (1.79) | 24 Jan 2025 |
| Q2 FY25Jul–Sep 2024 | 2.57 | −15.9% | (49.64) | Loss widened | (2.27) | 29 Oct 2024 |
| Q1 FY25Apr–Jun 2024 | 1.01 | −73.5% | (28.04) | Loss widened | (1.29) | 22 Aug 2024 |
| Q4 FY24Jan–Mar 2024 | 2.39 | −8.7% | (26.54) | Loss narrowed | (1.22) | 09 May 2024 |
| Q3 FY24Oct–Dec 2023 | 2.45 | −18.4% | (41.76) | Loss narrowed | (1.92) | 07 Feb 2024 |
| Q2 FY24Jul–Sep 2023 | 3.06 | −30.2% | (12.68) | Loss narrowed | (0.58) | 18 Nov 2023 |
| Q1 FY24Apr–Jun 2023 | 3.80 | +7.3% | (24.09) | Loss widened | (1.10) | 08 Aug 2023 |
| Q4 FY23Jan–Mar 2023 | 2.61 | −38.1% | (27.64) | Loss widened | (1.17) | 16 May 2023 |
| Q3 FY23Oct–Dec 2022 | 3.00 | −32.3% | (51.12) | Loss widened | (2.90) | 07 Feb 2023 |
| Q2 FY23Jul–Sep 2022 | 4.39 | +270.5% | (23.18) | Loss narrowed | (1.59) | 23 Nov 2022 |
| Q1 FY23Apr–Jun 2022 | 3.54 | +76.4% | (16.33) | Loss narrowed | (1.12) | 28 Jul 2022 |
| Q4 FY22Jan–Mar 2022 | 4.22 | +171.1% | (20.80) | Loss narrowed | (1.63) | 12 May 2022 |
| Q3 FY22Oct–Dec 2021 | 4.43 | +193.0% | (33.69) | Loss widened | (2.65) | 31 Jan 2022 |
| Q2 FY22Jul–Sep 2021 | 1.18 | −86.8% | (28.30) | Loss widened | (2.22) | 27 Oct 2021 |
| Q1 FY22Apr–Jun 2021 | 2.01 | +40.4% | (39.21) | Loss widened | (3.08) | 10 Aug 2021 |
| Q4 FY21Jan–Mar 2021 | 1.56 | −82.0% | (21.61) | Loss narrowed | (1.70) | 05 May 2021 |
| Q3 FY21Oct–Dec 2020 | 1.51 | −45.4% | (24.39) | Loss widened | (1.92) | 28 Jan 2021 |
| Q2 FY21Jul–Sep 2020 | 8.98 | −96.7% | (15.66) | Turned loss | (1.23) | 29 Oct 2020 |
| Q1 FY21Apr–Jun 2020 | 1.43 | −99.3% | (10.49) | Turned loss | (0.82) | 12 Aug 2020 |
| Q4 FY20Jan–Mar 2020 | 8.66 | — | (25.56) | — | (2.01) | 06 Jun 2020 |
| Q3 FY20Oct–Dec 2019 | 2.77 | — | (22.81) | — | (1.79) | 15 Feb 2020 |
| Q2 FY20Jul–Sep 2019 | 274.31 | — | 63.31 | — | 4.97 | 14 Nov 2019 |
| Q1 FY20Apr–Jun 2019 | 198.99 | — | 26.21 | — | 2.06 | 16 Aug 2019 |
| Q4 FY19Jan–Mar 2019 | 0.00 | — | 0.00 | — | 0.00 | 25 May 2019 |
Standalone results
| Quarter | Revenue | YoY | Net profit | YoY | EPS (₹) | Filed |
|---|---|---|---|---|---|---|
| Q1 FY27Apr–Jun 2026 | 3.57 | +91.0% | (16.12) | Loss widened | (0.61) | 06 Aug 2026 |
| Q4 FY26Jan–Mar 2026 | 1.52 | +3.6% | (11.17) | Loss narrowed | (0.50) | 28 May 2026 |
| Q3 FY26Oct–Dec 2025 | 2.81 | +74.5% | (13.47) | Loss widened | (0.60) | 29 Jan 2026 |
| Q2 FY26Jul–Sep 2025 | 0.92 | −64.3% | (15.45) | Loss widened | (0.70) | 11 Nov 2025 |
| Q1 FY26Apr–Jun 2025 | 1.87 | +85.6% | (14.78) | Loss widened | (0.68) | 13 Aug 2025 |
| Q4 FY25Jan–Mar 2025 | 1.47 | −38.5% | (15.07) | Loss widened | (0.69) | 13 May 2025 |
| Q3 FY25Oct–Dec 2024 | 1.61 | −34.3% | (13.27) | Loss widened | (0.61) | 24 Jan 2025 |
| Q2 FY25Jul–Sep 2024 | 2.57 | −15.9% | (11.07) | Turned loss | (0.51) | 29 Oct 2024 |
| Q1 FY25Apr–Jun 2024 | 1.01 | −73.5% | (7.67) | Loss widened | (0.35) | 22 Aug 2024 |
| Q4 FY24Jan–Mar 2024 | 2.39 | −8.7% | (3.12) | Loss widened | (0.14) | 09 May 2024 |
| Q3 FY24Oct–Dec 2023 | 2.45 | −18.4% | (4.77) | Loss narrowed | (0.22) | 07 Feb 2024 |
| Q2 FY24Jul–Sep 2023 | 3.06 | −30.2% | 2.75 | Turned profit | 0.13 | 18 Nov 2023 |
| Q1 FY24Apr–Jun 2023 | 3.80 | +7.3% | (2.87) | Loss widened | (0.13) | 08 Aug 2023 |
| Q4 FY23Jan–Mar 2023 | 2.61 | −38.1% | (2.25) | Loss narrowed | (0.05) | 16 May 2023 |
| Q3 FY23Oct–Dec 2022 | 3.00 | −32.3% | (6.63) | Loss narrowed | (0.35) | 07 Feb 2023 |
| Q2 FY23Jul–Sep 2022 | 4.39 | +270.5% | (8.93) | Loss narrowed | 0.61 | 23 Nov 2022 |
| Q1 FY23Apr–Jun 2022 | 3.54 | +76.4% | (2.31) | Loss narrowed | (0.16) | 28 Jul 2022 |
| Q4 FY22Jan–Mar 2022 | 4.22 | +171.1% | (8.55) | Loss widened | (0.67) | 12 May 2022 |
| Q3 FY22Oct–Dec 2021 | 4.43 | +193.0% | (8.22) | Loss widened | (0.65) | 31 Jan 2022 |
| Q2 FY22Jul–Sep 2021 | 1.18 | −86.8% | (10.98) | Loss widened | (0.86) | 27 Oct 2021 |
| Q1 FY22Apr–Jun 2021 | 2.01 | +40.4% | (8.49) | Loss widened | (0.67) | 10 Aug 2021 |
| Q4 FY21Jan–Mar 2021 | 1.56 | −82.0% | (8.51) | Loss widened | (0.67) | 05 May 2021 |
| Q3 FY21Oct–Dec 2020 | 1.51 | −45.4% | (8.15) | Loss widened | (0.64) | 28 Jan 2021 |
| Q2 FY21Jul–Sep 2020 | 8.98 | −96.7% | (1.90) | Turned loss | (0.15) | 29 Oct 2020 |
| Q1 FY21Apr–Jun 2020 | 1.43 | −99.3% | (4.08) | Turned loss | (0.32) | 12 Aug 2020 |
| Q4 FY20Jan–Mar 2020 | 8.66 | −96.6% | (2.56) | Turned loss | (0.20) | 06 Jun 2020 |
| Q3 FY20Oct–Dec 2019 | 2.77 | −97.9% | (4.50) | Turned loss | (0.35) | 15 Feb 2020 |
| Q2 FY20Jul–Sep 2019 | 274.31 | +206.4% | 72.32 | +301.6% | 5.68 | 14 Nov 2019 |
| Q1 FY20Apr–Jun 2019 | 198.99 | +3.8% | 57.18 | +47.2% | 4.49 | 16 Aug 2019 |
| Q4 FY19Jan–Mar 2019 | 253.30 | — | 67.98 | — | 5.34 | 25 May 2019 |
| Q3 FY19Oct–Dec 2018 | 129.02 | — | 25.23 | — | 1.98 | 06 Feb 2019 |
| Q2 FY19Jul–Sep 2018 | 89.52 | — | 18.01 | — | 1.41 | 20 Nov 2018 |
| Q1 FY19Apr–Jun 2018 | 191.66 | — | 38.84 | — | 3.05 | 20 Aug 2018 |
63 filings on record for this company.